Trial Profile
Prospecive study for treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA) and chemotherapy - AMLCG APL-1994 Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Tretinoin (Primary) ; Cyclophosphamide; Cytarabine; Cytarabine; Daunorubicin; Mitoxantrone; Tioguanine
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- Acronyms AMLCG-APL1994
- 27 Sep 2012 New trial record